Your browser doesn't support javascript.
loading
Trends in the Utilization of Palliative Care in Patients With Gynecologic Cancer Who Subsequently Died During Hospitalization.
Milki, Anthony; Mann, Amandeep Kaur; Gardner, Austin; Kapp, Daniel Stuart; English, Diana; Chan, John K.
Afiliação
  • Milki A; 43989George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
  • Mann AK; 33314Palo Alto Medical Foundation Research Institute, Palo Alto, CA, USA.
  • Gardner A; 12219University of California, Irvine School of Medicine, Irvine,CA, USA.
  • Kapp DS; Department of Radiation Oncology, 10624Stanford University School of Medicine, Stanford, CA, USA.
  • English D; Division of Gynecologic Oncology, 33697University of South Florida, Tampa, FL, USA.
  • Chan JK; Division of Palliative Medicine, 33697University of South Florida, Tampa, FL, USA.
Am J Hosp Palliat Care ; 38(2): 138-146, 2021 Feb.
Article em En | MEDLINE | ID: mdl-32633550
ABSTRACT

OBJECTIVE:

To determine factors associated with the utilization of palliative care (PC) in patients with metastatic gynecologic cancer who died while hospitalized.

METHODS:

Data were abstracted from the National Inpatient Sample database for patients with cervical, uterine, and ovarian cancers from 2005 to 2011. Chi-squared and logistic regression models were used for statistical analyses.

RESULTS:

Of 4559 women (median age 65 years; range 19-102), 1066 (23.4%) utilized PC. Patients were 24.9% low socioeconomic status (SES), 23.9% low-middle, 23.7% middle-high, and 25.1% high SES. Medicare, Medicaid, and private insurance coverage were listed at 46.2%, 37.5%, 11.3% of patients; 36.2%, 21.1%, 18.1%, 24.6% were treated in the South, West, Midwest, and Northeast. Over the 7 year study period, the use of PC increased from 12% to 45%. Older age (odds ratio [OR] 1.36; 95% CI 1.11-1.68; P = .003), high SES (OR 1.41; 95% CI 1.12-1.78; P = .003), more recent treatment (OR 9.22; 95% CI 6.8-12.51; P < .0001), private insurance (OR 1.81; 95% CI 1.46-2.25; P < .001), and treatment at large-volume hospitals (OR 1.36; 95% CI 1.04-1.77; P = .02), Western (OR 2.00; 95% CI 1.61-2.49; P < .001) and Midwestern hospitals (OR 1.35; 95% CI 1.08-1.68; P = .001) were associated with higher utilization of PC.

CONCLUSIONS:

The use of inpatient PC for patients with gynecologic cancer increased over time. The lower utilization of PC for terminal illness was associated with younger age, lower SES, government-issued insurance coverage, and treatment in Southern and smaller volume hospitals, and warrants further attention.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Enfermagem de Cuidados Paliativos na Terminalidade da Vida / Neoplasias dos Genitais Femininos Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Enfermagem de Cuidados Paliativos na Terminalidade da Vida / Neoplasias dos Genitais Femininos Idioma: En Ano de publicação: 2021 Tipo de documento: Article